Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;21(7):999-1007.
doi: 10.1007/s10552-010-9526-5. Epub 2010 Mar 4.

Cancer risk in DES daughters

Janneke Verloop  1 , Flora E van Leeuwen, Theo J M Helmerhorst, Hester H van Boven, Matti A Rookus
Affiliations

Cancer risk in DES daughters

Janneke Verloop et al. Cancer Causes Control. 2010 Jul.

Abstract

Objective: We examined long-term risk of cancer in women exposed to diethylstilbestrol (DES) in utero.

Methods: A total of 12,091 DES-exposed women in the Netherlands were followed prospectively from December 1992 till June 2008. Cancer incidence was assessed through linkage with the Dutch pathology database (PALGA) and the Netherlands Cancer Registry and compared with the Dutch female population.

Results: A total of 348 medically verified cancers occurred; median age at end of follow-up was 44.0 years. No overall increased risk of cancer was found (standardized incidence ratio [SIR] = 1.01; 95% confidence interval [CI] = 0.91, 1.13). The risk of clear cell adenocarcinoma of the vagina and cervix (CCA) was statistically significantly increased (SIR = 24.23; 95% CI = 8.89, 52.74); the elevated risk persisted above 40 years of age. The risk of melanoma diagnosed before age 40 was increased (SIR = 1.59; 95% CI = 1.08, 2.26). No excess risks were found for other sites, including breast cancer.

Conclusions: Except for an elevated risk of CCA, persisting at older ages, and an increased risk of melanoma at young ages, we found no increased risk of cancer. Longer follow-up is warranted to examine cancer risk at ages when cancer occurs more frequently.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Response rates of eligible cohort of DES daughters
See this image and copyright information in PMC

References

    1. Heinonen OP. Diethylstilbestrol in pregnancy. Frequency of exposure and usage patterns. Cancer. 1973;31(3):573–577. doi: 10.1002/1097-0142(197303)31:3<573::AID-CNCR2820310312>3.0.CO;2-#. - DOI - PubMed
    1. Noller KL, Fish CR. Diethylstilbestrol usage: its interesting past, important present, and questionable future. Med Clin North Am. 1974;58(4):793–810. - PubMed
    1. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971;284:878–881. - PubMed
    1. Giusti RM, Iwamoto K, Hatch EE. Diethylstilbestrol revisited: a review of the long-term health effects. [review] [113 refs] Ann Intern Med. 1995;122:778–788. - PubMed
    1. Newbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspect. 1995;103(Suppl 7):83–87. doi: 10.2307/3432514. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances